5FNC1†These authors contributed equally to this work.
5FNC2‡Present address: Division of Microbiology, Department of Pathological Sciences, Faculty of Medical Sciences, University of Fukui, Fukui 910-1193, Japan.
Hepatitis C virus (HCV) is the major causative agent of hepatocellular carcinoma. However, the precise mechanism underlying the carcinogenesis is yet to be elucidated. It has recently been reported that Syk, a non-receptor protein tyrosine kinase, functions as a potent tumour suppressor in human breast carcinoma. This study first examined the possible effect of HCV infection on expression of Syk in vivo. Immunohistochemical analysis revealed that endogenous Syk, which otherwise was expressed diffusely in the cytoplasm of normal hepatocytes, was localized near the cell membrane with a patchy pattern in HCV-infected hepatocytes. The possible interaction between HCV proteins and Syk in human hepatoma-derived Huh-7 cells was then examined. Immunoprecipitation analysis revealed that NS5A interacted strongly with Syk. Deletion-mutation analysis revealed that an N-terminal portion of NS5A (aa 1–175) was involved in the physical interaction with Syk. An in vitro kinase assay demonstrated that NS5A inhibited the enzymic activity of Syk and that, in addition to the N-terminal 175 residues, a central portion of NS5A (aa 237–302) was required for inhibition of Syk. Moreover, Syk-mediated phosphorylation of phospholipase C-γ1 was downregulated by NS5A. An interaction of NS5A with Syk was also detected in Huh-7.5 cells harbouring an HCV RNA replicon or infected with HCV. In conclusion, these results demonstrated that NS5A interacts with Syk resulting in negative regulation of its kinase activity. The results indicate that NS5A may be involved in the carcinogenesis of hepatocytes through the suppression of Syk kinase activities.
ChooQ. L.,
KuoG.,
WeinerA. J.,
OverbyL. R.,
BradleyD. W.,
HoughtonM.1989; Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362[CrossRef]
ChungK. M.,
LeeJ.,
KimJ. E.,
SongO. K.,
ChoS.,
LimJ.,
SeedorfM.,
HahmB.,
JangS. K.2000; Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin β 3. J Virol 74:5233–5241[CrossRef]
CoopmanP. J.,
DoM. T.,
BarthM.,
BowdenE. T.,
HayesA. J.,
BasyukE.,
BlancatoJ. K.,
VezzaP. R.,
McLeskeyS. W.other authors2000; The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature 406:742–747[CrossRef]
CoreyS. J.,
BurkhardtA. L.,
BolenJ. B.,
GeahlenR. L.,
TkatchL. S.,
TweardyD. J.1994; Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci U S A 91:4683–4687[CrossRef]
CostelloP. S.,
TurnerM.,
WaltersA. E.,
CunninghamC. N.,
BauerP. H.,
DownwardJ.,
TybulewiczV. L.1996; Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 13:2595–2605
DengL.,
Nagano-FujiiM.,
TanakaM.,
Nomura-TakigawaY.,
IkedaM.,
KatoN.,
SadaK.,
HottaH.2006; NS3 protein of hepatitis C virus associates with the tumor suppressor p53 and inhibits its function in an NS3 sequence-dependent manner. J Gen Virol 87:1703–1713[CrossRef]
DoiH.,
ApichartpiyakulC.,
OhbaK. I.,
MizokamiM.,
HottaH.1996; Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6. J Clin Microbiol 34:569–574
EvansM. J.,
RiceC. M.,
GoffS. P.2004; Phosphorylation of hepatitis C virus nonstructural protein 5A modulates its protein interactions and viral RNA replication. Proc Natl Acad Sci U S A 101:13038–13043[CrossRef]
GaleM.Jr,
BlakelyC. M.,
KwieciszewskiB.,
TanS. L.,
DossettM.,
TangN. M.,
KorthM. J.,
PolyakS. J.,
GretchD. R.,
KatzeM. G.1998; Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18:5208–5218
GaoL.,
AizakiH.,
HeJ. W.,
LaiM. M.2004; Interactions between viral nonstructural proteins and host protein hVAP-33 mediate the formation of hepatitis C virus RNA replication complex on lipid raft. J Virol 78:3480–3488[CrossRef]
HamamotoI.,
NishimuraY.,
OkamotoT.,
AizakiH.,
LiuM.,
MoriM.,
AbeT.,
SuzukiT.,
LaiM. M. C.other authors2005; Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol 79:13473–13482[CrossRef]
HeY.,
NakaoH.,
TanS. L.,
PolyakS. J.,
NeddermannP.,
VijaysriS.,
JacobsB. L.,
KatzeM. G.2002; Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase. J Virol 76:9207–9217[CrossRef]
HidajatR.,
Nagano-FujiiM.,
DengL.,
TanakaM.,
TakigawaY.,
KitazawaS.,
HottaH.2005; Hepatitis C virus NS3 protein interacts with ELKS- δ and ELKS- α , members of a novel protein family involved in intracellular transport and secretory pathways. J Gen Virol 86:2197–2208[CrossRef]
KanekoT.,
TanjiY.,
SatohS.,
HijikataM.,
AsabeS.,
KimuraK.,
ShimotohnoK.1994; Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem Biophys Res Commun 205:320–326[CrossRef]
KurosakiT.,
JohnsonS. A.,
PaoL.,
SadaK.,
YamamuraH.,
CambierJ. C.1995; Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling. J Exp Med 182:1815–1823[CrossRef]
LawC. L.,
ChandranK. A.,
SidorenkoS. P.,
ClarkE. A.1996; Phospholipase C- γ 1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol Cell Biol 16:1305–1315
LiJ.,
SidellN.2005; Growth-related oncogene produced in human breast cancer cells and regulated by Syk protein-tyrosine kinase. Int J Cancer 117:14–20[CrossRef]
MacdonaldA.,
CrowderK.,
StreetA.,
McCormickC.,
HarrisM.2004; The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity. J Gen Virol 85:721–729[CrossRef]
MaedaN.,
WatanabeM.,
OkamotoS.,
KanaiT.,
YamadaT.,
HataJ.,
HozumiN.,
KatsumeA.,
NuriyaH.other authors2004; Hepatitis C virus infection in human liver tissue engrafted in mice with an infectious molecular clone. Liver Int 24:259–267[CrossRef]
MajumderM.,
GhoshA. K.,
SteeleR.,
RayR.,
RayR. B.2001; Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J Virol 75:1401–1407[CrossRef]
MellorJ.,
HolmesE. C.,
JarvisL. M.,
YapP. L.,
SimmondsP.1995; Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. J Gen Virol 76:2493–2507[CrossRef]
MiahS. M.,
SadaK.,
TuazonP. T.,
LingJ.,
MaenoK.,
KyoS.,
QuX.,
TohyamaY.,
TraughJ. A.,
YamamuraH.2004; Activation of Syk protein tyrosine kinase in response to osmotic stress requires the interaction with p21-activated protein kinase Pak2/ γ -PAK. Mol Cell Biol 24:71–83[CrossRef]
MiyanariY.,
AtsuzawaK.,
UsudaN.,
WatashiK.,
HishikiT.,
ZayasM.,
BartenschlagerR.,
WakitaT.,
HijikataM.,
ShimotohnoK.2007; The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9:1089–1097[CrossRef]
MuramatsuS.,
IshidoS.,
FujitaT.,
ItohM.,
HottaH.1997; Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J Virol 71:4954–4961
PooleA.,
GibbinsJ. M.,
TurnerM.,
van VugtM. J.,
van de WinkelJ. G.,
SaitoT.,
TybulewiczV. L.,
WatsonS. P.1997; The Fc receptor γ -chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 16:2333–2341[CrossRef]
QadriI.,
IwahashiM.,
SimonF.2002; Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3. Biochim Biophys Acta 1592:193–204[CrossRef]
ReedK. E.,
RiceC. M.2000; Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 242:55–84
RobertsonB.,
MyersG.,
HowardC.,
BrettinT.,
BukhJ.,
GaschenB.,
GojoboriT.,
MaertensG.,
MizokamiM.other authors1998; Classification, nomenclature, and database development for hepatitis C virus (HCV) and related virus: proposals for standardization. Arch Virol 143:2493–2503[CrossRef]
SadaK.,
ZhangJ.,
SiraganianR. P.2000; Point mutation of a tyrosine in the linker region of Syk results in a gain of function. J Immunol 164:338–344[CrossRef]
SchneiderF.,
KieserA.2004; A novel assay to quantify cell death after transient expression of apoptotic genes in B- and T-lymphocytes. J Immunol Methods 292:165–174[CrossRef]
ShiS. T.,
PolyakS. J.,
TuH.,
TaylorD. R.,
GretchD. R.,
LaiM. M.2002; Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292:198–210[CrossRef]
ShiueL.,
GreenJ.,
GreenO. M.,
KarasJ. L.,
MorgensternJ. P.,
RamM. K.,
TaylorM. K.,
ZollerM. J.,
ZydowskyL. D.other authors1995; Interaction of p72 syk with the γ and β subunits of the high-affinity receptor for immunoglobulin E, FcϵRI. Mol Cell Biol 15:272–281
SimonM.,
VanesL.,
GeahlenR. L.,
TybulewiczV. L.2005; Distinct roles for the linker region tyrosines of Syk in FcϵRI signaling in primary mast cells. J Biol Chem 280:4510–4517[CrossRef]
SongJ.,
FujiiM.,
WangF.,
ItohM.,
HottaH.1999; The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J Gen Virol 80:879–886
TaguchiT.,
Nagano-FujiiM.,
AkutsuM.,
KadoyaH.,
OhgimotoS.,
IshidoS.,
HottaH.2004; Hepatitis C virus NS5A protein interacts with 2′,5′-oligoadenylate synthetase and inhibits antiviral activity of IFN in an IFN sensitivity-determining region-independent manner. J Gen Virol 85:959–969[CrossRef]
TakigawaY.,
Nagano-FujiiM.,
DengL.,
HidajatR.,
TanakaM.,
MizutaH.,
HottaH.2004; Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Microbiol Immunol 48:591–598[CrossRef]
TanS. L.,
NakaoH.,
HeY.,
VijaysriS.,
NeddermannP.,
JacobsB. L.,
MayerB. J.,
KatzeM. G.1999; NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A 96:5533–5538[CrossRef]
TellinghuisenT. L.,
MarcotrigianoJ.,
RiceC. M.2005; Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature 435:374–379[CrossRef]
TsuchidaS.,
YanagiS.,
InatomeR.,
DingJ.,
HermannP.,
TsujimuraT.,
MatsuiT.,
YamamuraH.2000; Purification of a 72-kDa protein-tyrosine kinase from rat liver and its identification as Syk: involvement of Syk in signaling events of hepatocytes. J Biochem 127:321–327[CrossRef]
WangS.,
DingY. B.,
ChenG. Y.,
XiaJ. G.,
WuZ. Y.2004; Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol 10:1815–1818
WienandsJ.,
LarboletteO.,
RethM.1996; Evidence for a preformed transducer complex organized by the B cell antigen receptor. Proc Natl Acad Sci U S A 93:7865–7870[CrossRef]
YamadaT.,
FujiedaS.,
YanagiS.,
YamamuraH.,
InatomeR.,
SunagaH.,
SaitoH.2001; Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production. J Immunol 166:538–543[CrossRef]
YanagiS.,
KurosakiT.,
YamamuraH.1995; The structure and function of nonreceptor tyrosine kinase p72SYK expressed in hematopoietic cells. Cell Signal 7:185–193[CrossRef]
YasuiK.,
WakitaT.,
Tsukiyama-KoharaK.,
FunahashiS. I.,
IchikawaM.,
KajitaT.,
MoradpourD.,
WandsJ. R.,
KoharaM.1998; The native form and maturation process of hepatitis C virus core protein. J Virol 72:6048–6055
YuanY.,
WangJ.,
LiM.,
YanZ.,
ZhangC.,
DaiJ. L.2006; Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma. Clin Cancer Res 12:6687–6695[CrossRef]
ZechB.,
KurtenbachA.,
KriegerN.,
StrandD.,
BlenckeS.,
MorbitzerM.,
SalassidisK.,
CottenM.,
WissingJ.other authors2003; Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein. J Gen Virol 84:555–560[CrossRef]
ZhangJ.,
BerensteinE.,
SiraganianR. P.2002; Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc-ϵRI signaling in mast cells. Mol Cell Biol 22:8144–8154[CrossRef]